drugset

drugset / Trial / NCT04222712

A Study to Evaluate TRS01 Eye Drops in Participants With Active Non-infectious Anterior Uveitis

NCT04222712 ↗

Phase 1/2 Completed 16 enrolled Tarsier Pharma

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to evaluate the safety of TRS01 eye drops in participants with active non-infectious anterior uveitis .

Timeline

Start: 2020-02-01
Primary completion: 2020-08-24
Completion: 2020-08-24

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	dazdotuftide	Small molecule	—	Topical

Indications